The annual impact of seasonal influenza in the US: Measuring disease burden and costs

Vaccine

Volumn 25, Issue 27, 2007, Pages 5086-5096

  Molinari, Noelle Angelique M ^a   Ortega Sanchez, Ismael R ^a   Messonnier, Mark L ^a   Thompson, William W ^b   Wortley, Pascale M ^a   Weintraub, Eric ^b   Bridges, Carolyn B ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Disease burden; Health care cost; Influenza; Productivity losses

Indexed keywords

ABSENTEEISM; AGE; ARTICLE; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION COST; INFLUENZA; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; PROBABILITY; PRODUCTIVITY; RISK; SEASONAL VARIATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; COSTS AND COST ANALYSIS; EFFICIENCY; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MONTE CARLO METHOD; REGRESSION ANALYSIS; RISK; SICK LEAVE; TREATMENT OUTCOME; UNITED STATES; VALUE OF LIFE;

EID: 34249938743     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.046     Document Type: Article

References (54)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55 RR10 (2006) 1-42
2. Meltzer M.I., Cox N.J., and Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 5 5 (1999) 659-671
3. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., and Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 7 35 (2003) 3-13 1
4. Schwartz B. An intranasal influenza vaccine for the prevention of influenza in healthy children was cost effective. Evid Based Med 7 2 (2002) 63
5. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 13 (2000) 1655-1663
6. Edwards K.M., Dupont W.D., Westrich M.K., Plummer W.D., Palmer P.S., and Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 169 (1994) 68-76
7. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., and Hess K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 15 10 (1997) 1114-1122
8. Neuzil K., Zhu Y., Griffin M., Edwards K.M., Thompson J., Tollefson S., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185 (2002) 147-152
9. Centers for Disease Control and Prevention National Center for Health Statistics. Vital statistics mortality data, multiple cause detail, 1972-1998 (1998), Centers for Disease Control and Prevention National Center for Health Statistics, Hyattsville, MD [public use data tapes contents and documentation package]
10. Mullooly J.P., and Barker W.H. Impact of type A influenza on children: a retrospective study. Am J Pub Health 72 9 (1982) 1008-1016
11. Hall M., and Owings M. 2000 National Hospital Discharge Survey. Adv Data 329 (2002) 1-18
12. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death, based on recommendations of the Ninth Revision Conference, 1975. Geneva; 1977.
13. Brammer T., Izurieta H., Fukuda K., Schmeltz L., Regnery H., Hall H., et al. Surveillance for influenza-United States, 1994-95, 1995-96, and 1996-97 seasons. MMWR CDC Surveill Summ 49 3 (2000) 13-28
14. Izurieta H., Thompson W., Kramarz P., Shay D., Davis R., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 4 (2000) 232-239
15. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
16. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N.J., Anderson L.J., et al. Mortality associated with influenza and respiratory synctial virus in the United States. JAMA 289 2 (2003) 179-186
17. Anderson R., Minino A., Hoyert D., and Rosenberg H. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 49 2 (2001) 1-32
18. Thompson W.W., Weintraub E., Shay D., Brammer L., Cox N., and Fukuda K. Health burden of influenza in healthy adults aged 18-49 years. Panel session presented at the Universal vaccination against influenza-are we ready?. Atlanta, GA (2005)
19. Mullooly J.P., Bridges C.B., Thompson W.W., Chen J., Weintraub E., Jackson L.A., et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 25 (2007) 846-855
20. Centers for Disease Control and Prevention. National health interview survey. National Center for Health Statistics; 2002.
21. O'Brien M.A., Uyeki T.M., Shay D.K., Thompson W.W., Kleinman K., McAdam A., et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 113 3 (2004) 585-589
22. Hurwitz E., Haber M., Chang A., Shope T., Teo S., Ginsberg M., et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 284 13 (2000) 1677-1682
23. Menec V.H., Black C., MacWilliam L., and Aoki F.Y. The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. Can J Public Health 94 1 (2003) 59-63
24. Arias E. United states life tables, 2003. Natl Vital Stat Rep 54 14 (2006) 1-40
25. Prosser L., O'Brien M.A., Molinari N.M., Hohman K., Nichol K.L., Wortley P., et al. Costs and cost-effectiveness of delivering adult influenza vaccination in non-traditional settings. Panel session presented at the 27th annual meeting of the society for medical decision making. San Francisco, CA (2005)
26. Prosser L.A., Bridges C.B., Uyeki T., et al. Should we vaccinate more children against influenza? projected health benefits, risks, and cost-effectiveness. Emerg Infect Dis 12 10 (2006) 1548-1558
27. U.S. Department of Labor BoLS. National compensation survey: occupational wages in the United States, July 2003. Summary 04-03; 2004.
28. Aldy JE, Viscusi WK. Age variations in workers' value of statistical life. NBER Working Paper Series. Working Paper 10199; 2003.
29. Haddix A., Teutsch S.M., and Corso P.S. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed. (2003), Oxford University Press
30. Viscusi W.K., and Aldy J.E. The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncert 27 (2003) 5-76
31. Spurr S.J. Economic foundations of law (2005), South-Western, Thomson, Mason, OH
32. @Risk Version 4.5.2 (2002), Palisade Corporation
33. The presidential/congressional commission on risk assessment and risk management. risk assessment and risk management in regulatory decision-making (1997), National Academy Press, Washington, DC
34. National Research Council CoRAoHAP. Science and judgement in risk assessment (1994), National Academy Press, Washington, DC
35. National Research Council CotIMfAoRtPH. Risk assessment in the federal government: managing the process (1983), National Academy Press, Washington, DC
36. Viscusi W. The value of risk to life and health. J Econ Literat 31 4 (1993) 1912-1946
37. Viscusi W., Magat W., and Forrest A. Altruistic and private valuations of risk reduction. J Policy Anal Manage 7 2 (1988) 227-245
38. Killingsworth M. Labor supply (1983), Princeton University Press, Princeton, NJ
39. Mincer J. Collected essays of Jacob Mincer vol. I (1993), Ashgate, Brookfield, VT
40. Mincer J. Collected essays of Jacob Mincer vol. II (1993), Ashgate, Brookfield, VT
41. Moody RJ. Employers pay a steep subsidy for programs. Bus J Portland 7 July, 2005: http://portland.bizjournals.com/portland/stories/2005/07/18/story1.html.
42. Thomson Medstat. Marketscan; 2003.
43. Skaggs D., Clemens S., Vitale M., Femino J., and Kay R. Access to orthopedic care for children with Medicaid versus private insurance. Pediatrics 107 (2001) 1405-1408
44. Strunk B., Ginsburg P., and Gabel J. Tracking health care costs: growth accelerates again in 2001. Health Affairs 20 6 (2001) 1-8
45. Orsini L., Rousculp M., Long S., and Wang S. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int 16 4 (2005) 359-371
46. Belshe R.B., and Gruber W.C. Safety, Efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Philos Trans R Soc Lond B Biol Sci 356 1416 (2001) 1947-1951
47. Mendelman P., Cordiva J., and Cho I. Safety, efficacy, and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine 19 17-19 (2001) 2221-2226
48. Beyer W.E., Palache A.M., de Jong J.C., and Osterhaus A.D. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20 9/10 (2002) 1340-1353
49. Glezen W., and Simonsen L. Benefits of influenza vaccine in US elderly-new studies raise questions. Int J Epidemiol 293 1 (2005) 1-2
50. Jefferson T., Rivetti D., Rudin M., Di Petrantonj C., and Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366 (2005) 1165-1174
51. Simonsen L., Viboud C., and Taylor R. Influenza vaccination in elderly people. Lancet 366 (2005) 2086
52. Yogev R. Influenza vaccine confusion: a call for an alternative evidence-based approach. Pediatrics 116 (2005) 1214-1215
53. Helms C., Guerra F.A., Klein J.O., Schaffner W., Arvin A., and Peter G. Strengthening the nation's influenza vaccination system: a National Vaccine Advisory Committee assessment. Am J Prev Med 29 3 (2005) 221-226
54. In: Tan L., and Strikas R (Eds). National influenza vaccine summit: minutes of meeting. Atlanta, GA (2006)